Cargando…

Changing the face of thyroid eye disease

Detalles Bibliográficos
Autores principales:	Ugradar, Shoaib, Goldberg, Robert A., Douglas, Raymond S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873613/ https://www.ncbi.nlm.nih.gov/pubmed/35882983 http://dx.doi.org/10.1038/s41433-022-02186-0

Ejemplares similares

Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Improvement of asymmetric thyroid eye disease with teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2022)

Teprotumumab for thyroid eye disease: early response is not required for benefit
por: Ugradar, Shoaib, et al.
Publicado: (2021)

LBSAT238 Teprotumumab Reduces Orbital Fat And Muscle Volume In Patients With Thyroid Eye Disease
por: Ugradar, Shoaib
Publicado: (2022)

Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021)

RF35 | PSAT268 Reversal of Graves’ Disease Associated Facial Volume Expansion and Eyelid Changes Following Teprotumumab Therapy
por: Ugradar, Shoaib, et al.
Publicado: (2022)

In Vivo Measurement of the Human Vitreous Chamber Volume Using Computed Tomography Imaging of 100 Eyes
por: Azhdam, Ariel M., et al.
Publicado: (2020)

Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison
por: Douglas, Raymond S., et al.
Publicado: (2022)

Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi Approach
por: Douglas, Raymond S., et al.
Publicado: (2022)

Thyroid dermopathy responds to teprotumumab therapy
por: Crespo-Trevino, Ricaurte, et al.
Publicado: (2022)

FRI545 Durability Of Treatment Response With VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor, In Patients With Thyroid Eye Disease (TED): Phase 1/2 Clinical Study
por: Douglas, Raymond, et al.
Publicado: (2023)

Increased incidence of chalazion associated with face mask wear during the COVID-19 pandemic
por: Silkiss, Rona Z, et al.
Publicado: (2021)

The Janus faces of thyroid carcinoma
Publicado: (2018)

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
por: Wang, Yao, et al.
Publicado: (2019)

A bright new outlook on thyroid eye disease
por: Kikkawa, Don O.
Publicado: (2022)

Medical management of thyroid eye disease – A paradigm shift
por: Honavar, Santosh G
Publicado: (2020)

Beyond a Typical Thyroid Eye Disease
por: Kashkouli, Mohsen Bahmani
Publicado: (2013)

Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
por: Kossler, Andrea Lora, et al.
Publicado: (2022)

Biomechanical and Morphologic Effects of Collagen Cross-Linking in Human Tarsus
por: Ugradar, Shoaib, et al.
Publicado: (2019)

Changing face of glaucoma
por: Natarajan, Sundaram
Publicado: (2014)

The changing faces of migraine
por: Martelletti, Paolo, et al.
Publicado: (2019)

The changing face of hepatology
por: Berenguer, Marina
Publicado: (2019)

The Changing Face of Occupational Medicine
Publicado: (2007)

The Changing Face of Primary Hyperparathyroidism
por: Parmar, Girish, et al.
Publicado: (2018)

Unilateral cilioretinal artery occlusion following cannabis use
por: Ugradar, Shoaib, et al.
Publicado: (2019)

The changing face of the European Respiratory Review
por: Harari, Sergio
Publicado: (2018)

The changing face of MedEdPublish
por: Hays, Richard, et al.
Publicado: (2021)

The changing face of the modern respiratory clinician
por: Kent, Brian D.
Publicado: (2023)

Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Plasmacytomas: many faces of one disease, or many diseases with one face?
por: Goyal, Gaurav, et al.
Publicado: (2019)

Pandemics, climate change, and the eye
por: El Hamichi, Sophia, et al.
Publicado: (2020)

Changing inclinations of eye banking
por: Vanathi, M
Publicado: (2023)

Changing face of pharmacology practicals for medical undergraduates
por: Desai, Mira
Publicado: (2009)

Coastal Biotechnology: Facing the Global and the Regional Changes
por: Qin, Song, et al.
Publicado: (2014)

Magnetic resonance imaging in thyroid eye disease: Signal intensity ratio to measure disease activity
por: Rath, Suryasnata
Publicado: (2022)

Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Thyroid Eye Disease
por: Rashad, Ramy, et al.
Publicado: (2022)

Thyroid eye disease /
por: Char, Devron H., 1945-
Publicado: (1990)

Our Role in the Changing Face of Research
por: Prabhakar, A. R.
Publicado: (2020)

Ocular Surface Changes in Treatment-Naive Thyroid Eye Disease
por: Liao, Xulin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9k3am0b1933163nknfilkpbi49